These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24378468)

  • 1. Screening of lysosomal storage disorders: application of the online trapping-and-cleanup liquid chromatography/mass spectrometry method for mucopolysaccharidosis I.
    Ombrone D; Malvagia S; Funghini S; Giocaliere E; Della Bona ML; Forni G; De Luca A; Villanelli F; Casetta B; Guerrini R; la Marca G
    Eur J Mass Spectrom (Chichester); 2013; 19(6):497-503. PubMed ID: 24378468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A column-switching HPLC-MS/MS method for mucopolysaccharidosis type I analysis in a multiplex assay for the simultaneous newborn screening of six lysosomal storage disorders.
    Gucciardi A; Legnini E; Di Gangi IM; Corbetta C; Tomanin R; Scarpa M; Giordano G
    Biomed Chromatogr; 2014 Aug; 28(8):1131-9. PubMed ID: 24449175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combined use of enzyme activity and metabolite assays as a strategy for newborn screening of mucopolysaccharidosis type I.
    Polo G; Gueraldi D; Giuliani A; Rubert L; Cazzorla C; Salviati L; Marzollo A; Biffi A; Burlina AP; Burlina AB
    Clin Chem Lab Med; 2020 Nov; 58(12):2063-2072. PubMed ID: 32432561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosing lysosomal storage disorders: mucopolysaccharidosis type I.
    Johnson BA; Dajnoki A; Bodamer OA
    Curr Protoc Hum Genet; 2015 Jan; 84():17.17.1-17.17.8. PubMed ID: 25599668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taiwan National Newborn Screening Program by Tandem Mass Spectrometry for Mucopolysaccharidoses Types I, II, and VI.
    Chan MJ; Liao HC; Gelb MH; Chuang CK; Liu MY; Chen HJ; Kao SM; Lin HY; Huang YH; Kumar AB; Chennamaneni NK; Pendem N; Lin SP; Chiang CC
    J Pediatr; 2019 Feb; 205():176-182. PubMed ID: 30409495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis I.
    Blanchard S; Sadilek M; Scott CR; Turecek F; Gelb MH
    Clin Chem; 2008 Dec; 54(12):2067-70. PubMed ID: 19042989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple and rapid method based on liquid chromatography-tandem mass spectrometry for the measurement of α-L-iduronidase activity in dried blood spots: an application to mucopolysaccharidosis I (Hurler) screening.
    Yang JS; Min HK; Oh HJ; Woo HI; Lee SY; Kim JW; Song J; Park HD
    Ann Lab Med; 2015 Jan; 35(1):41-9. PubMed ID: 25553279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass Spectrometry.
    Elliott S; Buroker N; Cournoyer JJ; Potier AM; Trometer JD; Elbin C; Schermer MJ; Kantola J; Boyce A; Turecek F; Gelb MH; Scott CR
    Mol Genet Metab; 2016 Aug; 118(4):304-9. PubMed ID: 27238910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of Liquid Chromatography-Tandem Mass Spectrometry-Based 5-Plex Assay for Mucopolysaccharidoses.
    Oguni T; Tomatsu S; Tanaka M; Orii K; Fukao T; Watanabe J; Fukuda S; Notsu Y; Vu DC; Can TBN; Nagai A; Yamaguchi S; Taketani T; Gelb MH; Kobayashi H
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32188102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of mucopolysaccharidosis I heterozygotes based on biochemical characteristics of L-iduronidase from dried blood spots.
    Campos D; Monaga M; González EC; Herrera D
    Clin Chim Acta; 2014 Mar; 430():24-7. PubMed ID: 24389097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status of newborn screening and follow up investigations for Mucopolysaccharidoses I and II in Taiwan.
    Chuang CK; Lin HY; Wang TJ; Huang YH; Chan MJ; Liao HC; Lo YT; Wang LY; Tu RY; Fang YY; Chen TL; Ho HC; Chiang CC; Lin SP
    Orphanet J Rare Dis; 2018 May; 13(1):84. PubMed ID: 29801497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn screening for lysosomal storage disorders by tandem mass spectrometry in North East Italy.
    Burlina AB; Polo G; Salviati L; Duro G; Zizzo C; Dardis A; Bembi B; Cazzorla C; Rubert L; Zordan R; Desnick RJ; Burlina AP
    J Inherit Metab Dis; 2018 Mar; 41(2):209-219. PubMed ID: 29143201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a fast LC-MS/MS protocol for combined measurement of six LSDs on dried blood spot in a newborn screening program.
    Scolamiero E; Casetta B; Malvagia S; Tanigawa T; Forni G; Funghini S; Mura M; Raspini F; Poggiali S; la Marca G
    J Pharm Biomed Anal; 2019 Feb; 165():135-140. PubMed ID: 30530130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn screening of mucopolysaccharidosis type I.
    Burlina AB; Gragnaniello V
    Crit Rev Clin Lab Sci; 2022 Jun; 59(4):257-277. PubMed ID: 35037566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tandem mass spectrometric analysis of dried blood spots for screening of mucopolysaccharidosis I in newborns.
    Wang D; Eadala B; Sadilek M; Chamoles NA; Turecek F; Scott CR; Gelb MH
    Clin Chem; 2005 May; 51(5):898-900. PubMed ID: 15695324
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of infants at risk for developing Fabry, Pompe, or mucopolysaccharidosis-I from newborn blood spots by tandem mass spectrometry.
    Scott CR; Elliott S; Buroker N; Thomas LI; Keutzer J; Glass M; Gelb MH; Turecek F
    J Pediatr; 2013 Aug; 163(2):498-503. PubMed ID: 23465405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot newborn screening program for Mucopolysaccharidosis type I in Taiwan.
    Lin SP; Lin HY; Wang TJ; Chang CY; Lin CH; Huang SF; Tsai CC; Liu HL; Keutzer J; Chuang CK
    Orphanet J Rare Dis; 2013 Sep; 8():147. PubMed ID: 24053568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplex Tandem Mass Spectrometry Enzymatic Activity Assay for Newborn Screening of the Mucopolysaccharidoses and Type 2 Neuronal Ceroid Lipofuscinosis.
    Liu Y; Yi F; Kumar AB; Kumar Chennamaneni N; Hong X; Scott CR; Gelb MH; Turecek F
    Clin Chem; 2017 Jun; 63(6):1118-1126. PubMed ID: 28428354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newborn screening for six lysosomal storage disorders in a cohort of Mexican patients: Three-year findings from a screening program in a closed Mexican health system.
    Navarrete-Martínez JI; Limón-Rojas AE; Gaytán-García MJ; Reyna-Figueroa J; Wakida-Kusunoki G; Delgado-Calvillo MDR; Cantú-Reyna C; Cruz-Camino H; Cervantes-Barragán DE
    Mol Genet Metab; 2017 May; 121(1):16-21. PubMed ID: 28302345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-incubation mass spectrometry assay for lysosomal storage disorders in newborn and high-risk population screening.
    Mechtler TP; Metz TF; Müller HG; Ostermann K; Ratschmann R; De Jesus VR; Shushan B; Di Bussolo JM; Herman JL; Herkner KR; Kasper DC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 908():9-17. PubMed ID: 23122395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.